Erk1 positively regulates osteoclast differentiation and bone resorptive activity - Wikidata - awgldk - TriplyDB

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

http://www.wikidata.org/entity/Q35227805

about

Redundancy in the World of MAP Kinases: All for One ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?Signaling Pathways in Osteoclast Differentiation Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling.ERK1 regulates the hematopoietic stem cell niches Aryl hydrocarbon receptors in osteoclast lineage cells are a negative regulator of bone mass.Molecular signaling pathways mediating osteoclastogenesis induced by prostate cancer cells.Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression.Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function Pheromone-induced morphogenesis and gradient tracking are dependent on the MAPK Fus3 binding to Gα.NRROS Negatively Regulates Osteoclast Differentiation by Inhibiting RANKL-Mediated NF-N:B and Reactive Oxygen Species Pathways.The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.Syndromic craniosynostosis associated with microdeletion of chromosome 19p13.12-19p13.2.Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway.STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis Activation of adenosine A(2A) receptor reduces osteoclast formation via PKA- and ERK1/2-mediated suppression of NFκB nuclear translocation Bone resorption is regulated by cell-autonomous negative feedback loop of Stat5-Dusp axis in the osteoclast.Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity.Pathways for bone loss in inflammatory disease.DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma.Platelet-derived growth factor BB enhances osteoclast formation and osteoclast precursor cell chemotaxis.Ellagic acid inhibits RANKL-induced osteoclast differentiation by suppressing the p38 MAP kinase pathway.Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis.Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions.Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.Inhibitory effects of eugenol on RANKL-induced osteoclast formation via attenuation of NF-κB and MAPK pathways.Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover.Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation.CD11b promotes the differentiation of osteoclasts induced by RANKL through the spleen tyrosine kinase signalling pathway.Inhibitory effects of sesamin on human osteoclastogenesis.Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a.Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.

P2860

Q26742080-D97F5BDD-00CD-410C-93D5-13370D69E550 Q26744787-CFA5166E-C732-437B-8CE8-8968C17FEBA1 Q26766637-A258557F-2287-45FE-A1E5-AA47281AC692 Q28550685-B8D9406F-F2D8-4DDB-84BF-A789818AA96C Q33820660-7EEDAFAF-D61E-4F9C-9AC4-AF0D2439A89D Q33844646-343446C2-E284-4FF9-9D3B-528E8E3E5F5B Q34150006-CB9DC06C-2A04-4F3C-B0E6-8923390BE975 Q35007314-144C2375-92C3-4D85-A208-2E9B5417A34A Q35076418-BD481B93-7631-4509-B315-219498D56FD0 Q35577020-7AB5FFE4-A853-43BB-A38A-36396CBE9078 Q35745300-6EFEEC58-B978-4D70-B023-D74F64AAB128 Q35953074-C7CCF745-CA33-46AF-B2CC-232B50C51FF5 Q36058470-37F2828E-F872-4A79-B822-A7B6DF27A41F Q36221462-E4E3D083-963C-4412-AA79-64DD7012F3FB Q36362544-CE1ED771-5893-49C3-BC31-DF7DECE8354C Q36380904-0576B37F-9F25-4F9E-A2C0-7F732E5B80BD Q36664333-DD3D87E7-5C8D-48CE-80EB-F71EB6B8DE93 Q36867284-0276B15A-3567-4F73-A748-5EC3C1C414A6 Q37071329-D6CA5DB3-3669-4330-88EE-5EC5C8F26A98 Q37148066-54DE6BAB-3138-43A0-87E8-1BF5CD0235B6 Q37318889-9B3D7016-2872-44DF-A62E-92810BB94D4C Q37483129-CC762320-435F-479E-9579-35356507F212 Q37699040-0D1C9EB8-98B9-4577-80FB-74BEA5ECC306 Q38004935-5A32EA1E-042F-4676-BEC4-BE5E87DCEB70 Q38709277-E5151392-B407-453F-BF30-FC911C99BAC3 Q38716386-C32379E7-8D48-4673-B10D-D37FD2BFBE16 Q38746329-0FBAF1C7-3B0D-4CCB-8047-D7FF07ED3B46 Q38759519-05991C4C-A24F-421E-AA95-E7C9385ECE7A Q38815172-8765DC3E-808F-40C7-B339-604383909372 Q42368951-B6AC1E49-492C-47A2-9B6A-B8801357A7F3 Q42918689-8F643605-15A4-4B95-8110-4B0F9E58B2D4 Q46145950-8BA13688-53B0-40D5-8796-D73ADD156AD6 Q46486673-E515D359-1DC8-462B-9EA5-09D34460498C Q47131626-94394601-9862-4E18-A32A-CC4DF56B0ABB Q47148757-4235F858-FA29-4AA1-9ED1-80E40388C8FC Q47730277-7A7F1CAF-B299-4911-A704-9ED8F4E37F0A Q50576290-10306102-3090-4A13-A839-68248FB7AE3E Q51024880-98F752B7-33B6-4C72-8815-2F247A12CA12

P2860

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

http://www.wikidata.org/entity/Q35227805

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

@ast

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

@en

type

label

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

@ast

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

@en

prefLabel

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

@ast

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

@en

P1433

Q35227805-3848259F-DFF3-45D9-AB82-E8E7B07265CB

P1476

Q35227805-30270CE6-2280-4F7D-8FA7-1004761BC965

P2093

Q35227805-054C3D56-0699-4D40-B3A6-97F79A5ADFDE

Q35227805-2438A424-D349-496B-8B80-F8E3CC5950E8

Q35227805-73166B04-AB0A-4780-A040-A61F7344C7A4

Q35227805-73F707C9-DD57-4905-9AE1-AFAAEF790652

Q35227805-7680BDC1-702A-497D-B34C-AA2BC16A7A5F

Q35227805-7B2C5BE0-0A21-4080-A837-6D4C3089D9C9

Q35227805-89E06E00-59B8-4C9F-87F8-36E47C7613EE

Q35227805-9733B8BD-6171-4F53-B63B-16F02F82E20D

Q35227805-D67AA564-6CDF-418B-B86B-495E049E85FD

Q35227805-E84F702E-F1C0-43CB-A0C0-E97AD706B43B

P2860

Q35227805-0E10EA3A-3F51-4F2E-A388-162088FE6604

Q35227805-22D2D767-73AC-4894-AE62-40FB4BC2A00A

Q35227805-23809386-F468-4A0E-8514-FD72060F959C

Q35227805-247EDB26-8AB4-4E0B-A3E9-DA14373AAA5E

Q35227805-259EF8E0-65E3-4BAB-88DC-8C1F3C167D82

Q35227805-2DA90034-45F5-4638-8B34-002F590E67D4

Q35227805-31C7F9C2-D73D-4120-BF52-6BC801313DA6

Q35227805-3311307F-E17F-4013-9DB3-238F6CA72772

Q35227805-33294FC2-AEAA-411C-9690-CA2DD664E8FD

Q35227805-3B127FBA-EF87-4EC7-BDE6-4DF1536D6F8D

P304

Q35227805-D729A5AA-33D2-4B1C-AA83-68F5ADBD3E1C

P31

Q35227805-43998FD9-E57C-4F52-8A73-FB43DF29E3C3

P356

Q35227805-0EE04E62-801C-46FD-94F7-7B273FEE1D9D

P407

Q35227805-EDDA816C-E143-46C7-810E-1A4C3D5ABA10

P433

Q35227805-30D3677E-496B-4A7E-B6B3-69E4C230BE9D

P478

Q35227805-C135C8E1-AD16-4122-996D-BA24CC159F2F

P577

Q35227805-3E82FF2A-C696-4139-AA34-78D2A3BE22F6

P5875

Q35227805-1E5A1CE4-4247-4267-8D59-FCF353BFED88

P698

Q35227805-726F0C4A-31A7-47E2-9C09-EE360D85D2D0

P932

Q35227805-65AF32AA-756F-45D1-9ED8-D9D33ECCC7A9

P356

JOURNAL.PONE.0024780

P1433

P1476

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

@en

P2093

Feng-Chun Yang

http://www.w3.org/2001/XMLSchema#string

Jin Yuan

http://www.w3.org/2001/XMLSchema#string

Karl Staser

http://www.w3.org/2001/XMLSchema#string

Li Jiang

http://www.w3.org/2001/XMLSchema#string

Shi Chen

http://www.w3.org/2001/XMLSchema#string

Steven D Rhodes

http://www.w3.org/2001/XMLSchema#string

Su-Jung Park

http://www.w3.org/2001/XMLSchema#string

Xianlin Yang

http://www.w3.org/2001/XMLSchema#string

Xiaohong Li

http://www.w3.org/2001/XMLSchema#string

Xiaohua Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein

Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Crystal structure of human mono-phosphorylated ERK1 at Tyr204

Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development

P304

e24780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0024780

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51683188

http://www.w3.org/2001/XMLSchema#string

P698

21961044

http://www.w3.org/2001/XMLSchema#string

P932

3178550

http://www.w3.org/2001/XMLSchema#string